Stephen M. Schwartz, PhD, MPH
Dr. Schwartz is currently the Epidemiology Graduate Program Director.
Fred Hutchinson Cancer Research Center
Box 358080 M4-C308
1100 Fairview Ave N., Building M
PO Box 19024, Mailstop: M4-C308
Seattle, WA 98109-1024
University of Washington
Dept. of Epidemiology
1959 NE Pacific Street
Health Sciences F-261F
Seattle, WA 98195-7236
Dr. Schwartz primarily studies the etiology and outcomes of cancer. A major objective of his research is to determine the influence of genetic susceptibility, either alone or in combination with lifestyle and environmental risk factors. Current funded research projects include studies focusing on the genetic and non-genetic risk factors for HPV-cancers and testicular germ cell tumors. Other areas of cancer research focus on molecular markers for oral cancer outcomes and the health and well-being of adolescent and young adult cancer survivors. Among his other responsibilities in the field of cancer epidemiology, he serves as Principal Investigator of the Cancer Surveillance System, a population-based cancer registry at the Fred Hutchinson Cancer Research Center.
Dr. Schwartz currently teaches "Methods and Issues in Using Biological Measurements in Epidemiologic Research" (EPI573) offered in the Fall Quarter of odd-numbered years and"Introduction to Laboratory Methods in Public Health Sciences" (EPI574) in the Winter Quarter of odd-numbered years.
PhD, Epidemiology, University of Washington 1990
MPH, Epidemiology, Yale University 1984
For research projects go to: http://faculty.washington.edu/stevesch/resframe.htm
Edelstein Z, Schwartz SM, Hawes SE, Hughes JP, Q Feng, Stern ME, O'Reilly S, Lee S-K, Xi LF, Koutsky LA. Rates and determinants of oral human papillomavirus (HPV) infection in young men. Sex Trans Dis in press
Sathyanarayana S, Swan SH, Farin FM, Wilkerson HW, Grady R, Zhou C, Schwartz SM. A pilot study of the association between genetic polymorphisms involved in estrogen signaling and infant male genital phenotypes. Asia J Androl 2012 Sep;14(5):766-72.
Sharma A, Mendez E, Yueh B, Lohavanichbutr P, Houck J, Doody DR, Futran ND, Upton MP, Schwartz SM, Chen C. HPV-positive oral cavity and oropharyngeal cancer patients do not have better QOL trajectories. Otolaryngology - Head and Neck Surgery 2012 May;146(5):739-45.
Stott-Miller M, Chen C, Chuang S-C, Lee Y-C A, Boccia S, Brenner H, Cadoni G, Dal Maso L, La Vecchia C, Lazarus P, Levi F, Matsuo K, Morgenstern H, Muller F, Muscat J, Olshan AF, Purdue MP, Serraino D, Vaughan TL, Zhang Z-F, Boffetta P, Hashibe M, Schwartz SM. History of diabetes and risk of head and neck cancer: a pooled analysis from the International Head and Neck Cancer Epidemiology (INHANCE) Consortium. Cancer Epidemiol Biomarkers Prev 2012 Feb;21(2):294-304.
Bodelon C, Madeleine MM, Johnson LG, Du Q, Malkki M, Petersdorf EW, Schwartz SM. Genetic variation in CD83 and risks of cervical and vulvar cancers: a population-based case-control study.Gynecol Oncol 2012 Mar;124(3):525-8.
For more publications:http://faculty.washington.edu/stevesch/pubframe.htm
In the news
Marijuana Use Linked to Testicular Cancer (The Onion)
Last Reviewed on 1/17/2012